CNMD - CONMED - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CNMD is currently covered by 6 analysts with an average price target of $53.57. This is a potential upside of $10.66 (24.84%) from yesterday's end of day stock price of $42.91.

CONMED's activity chart (see below) currently has 191 price targets and 123 ratings on display. The stock rating distribution of CNMD is 38.46% BUY and 61.54% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.55% with an average time for these price targets to be met of 151.58 days.

Highest price target for CNMD is $61, Lowest price target is $47, average price target is $54.67.

Most recent stock forecast was given by TRAVIS STEED from BAML on 08-Dec-2025. First documented stock forecast 16-Jan-2015.

Currently out of the existing stock ratings of CNMD, 5 are a BUY (38.46%), 8 are a HOLD (61.54%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 02-Mar-2022

$52

$9.09 (21.18%)

$125

1 months 3 days ago
(08-Dec-2025)

0/4 (0%)

$11.43 (28.17%)

Buy

Since 31-Oct-2019

$55

$12.09 (28.18%)

$68

2 months 5 days ago
(06-Nov-2025)

15/23 (65.22%)

$10.79 (24.41%)

221

Hold

Since 25-Apr-2024

$47

$4.09 (9.53%)

$57

2 months 5 days ago
(06-Nov-2025)

2/5 (40%)

$2.79 (6.31%)

13

Hold

Since 12-Jun-2025

$61

$18.09 (42.16%)

$61

6 months 30 days ago
(12-Jun-2025)

20/37 (54.05%)

$6.44 (11.80%)

270

Hold

Since 06-Feb-2025

$58

$15.09 (35.17%)

$70

8 months 10 days ago
(01-May-2025)

4/8 (50%)

$1.23 (2.17%)

157

Show more analysts

Please expand the browser size to see the chart

What is CNMD (CONMED) average time for price targets to be met?

On average it took 151.58 days on average for the stock forecasts to be realized with a an average price target met ratio 62.55

Which analyst has the current highest performing score on CNMD (CONMED) with a proven track record?

MATT O'BRIEN

Which analyst has the most public recommendations on CNMD (CONMED)?

Matt O'brien works at PIPER SANDLER and has 39 price targets and 26 ratings on CNMD

Which analyst is the currently most bullish on CNMD (CONMED)?

Matthew Mishan with highest potential upside - $98.09

Which analyst is the currently most reserved on CNMD (CONMED)?

Matthew Taylor with lowest potential downside - -$15.85

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?